Recent Developments in the Human Nutrition of Polyunsaturated Fatty Acids from Single Cell Oils

Single Cell Oils: Microbial and Algal Oils: Second Edition

Volumn , Issue , 2010, Pages 369-387

  Kuratko, Connye N ^a   Hoffman, James P ^a   Van Elswyk, Mary E ^a   Salem, Norman ^a  

^a Martek Biosciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84940266449     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-893997-73-8.50021-9     Document Type: Chapter

References (64)

1. Aggett P.J., Agostoni C., Axelsson I., De Curtis M., Goulet O., Hernell O., Koletzko B., Lafeber H.N., Michaelsen K.F., ESPGHAN Committee on Nutrition, et al. Feeding Preterm Infants after Hospital Discharge: A Commentary by the ESPGHAN Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2006, 42:596-603.
2. Agostoni C., Zuccotti G.V., Radaelli G., Besana R., Podestà A., Sterpa A., Rottoli A., Riva E., Giovannini M. Docosahexaenoic Acid Supplementation and Time at Achievement of Gross Motor Milestones in Healthy Infants: A Randomized, Prospective, Double-blind, Placebo-controlled Trial. Am. J. Clin. Nutr. 2009, 89:64-70.
3. Press Release. Results from Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline. Vienna, Austria. International Conference on Alzheimer's Disease (ICAD), July 12, 2009. http://www.alz.org/icad/2010_release_071209.
4. American Heart Association Common Misconceptions About High Blood Pressure (Accessed Apr 15, 2009). http://www.americanheart.org/presenter.jhtml;jsessionid=CPAUCL00ZTCWSCQFCXPSCZQ?identifier=3008517.
5. American Heart Association, American Stroke Association Know the Facts, Get the Stats (Accessed Apr 15, 2009). http://www.americanheart.org/downloadable/heart/116861545709855-1041%20KnowTheFactsStats07_loRes.pdf.
6. Arterburn L.M., Oken H.A., Bailey Hall E., Hamersley J., Kuratko C.N., Hoffman J.P. Algal-Oil Capsules and Cooked Salmon: Nutritionally Equivalent Sources of Docosahexaenoic Acid. J. Am. Diet. Assoc. 2008, 108:1204-1209.
7. Balk E.M., Lichtenstein A.H., Chung M., Kupelnic B., Chew P., Lau J. Effects of Omega-3 Fatty Acids on Serum Markers of Cardiovascular Disease Risk: A Systematic Review. Atherosclerosis 2006, 18:19-30.
8. Bays H. Rationale for Prescription Omega-3-acid Ethyl Ester Therapy for Hypertriglyceridemia: A Primer for Clinicians. Drugs Today (Barc). 2008, 44:205-246.
9. Birch E.E., Castaneda Y.S., Wheaton D.H., Birch D.G., Uauy R.D., Hoffman D.R. Visual Maturation of Term Infants Fed Long-Chain Polyunsaturated Fatty Acid-Supplemented or Control Formula for 12 Mo. Am. J. Clin. Nutr. 2005, 81:871-879.
10. Burks W., Jones S.M., Berseth C.L., Harris C., Sampson H.A., Scalabrin D.M. Hypoallergenicity and Effects on Growth and Tolerance of a New Amino Acid-Based Formula with Docosahexaenoic Acid and Arachidonic Acid. J. Pediatr. 2008, 153:266-271.
11. Carlson S.E., Werkman S.H., Tolley E.A. Effect of Long-Chain n-3 Fatty Acid Supplementation on Visual Acuity and Growth of Preterm Infants with and without Bronchopulmonary Dysplasia. Am. J. Clin. Nutr. 1996, 63:687-697.
12. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Intrauterine Fatty Acid Accretion Rates in Human Brain: Implications for Fatty Acid Requirements. Early Hum. Dev. 1980, 4:121-129.
13. Clandinin M.T., Van Aerde J.E., Merkel K.L., Harris C.L., Springer M.A., Hansen J.W., Diersen-Schade D.A. Growth and Development of Preterm Infants Fed Infant Formulas Containing Docosahexaenoic Acid and Arachidonic Acid. J Pediatr. 2005, 146:461-468.
14. Codex Alimentarius Commission Report of the 28th Session of the CODEX Committee on Nutrition and Foods For Special Dietary Uses. Codex Alimentarius Commission, Revised July 2007 (accessed Apr 2, 2009). http://www.codexalimentarius.net/download/standards/288/CXS_072e.pdf.
15. The Commission of the European Communities Commission Directive 2006/141/EC of 22 December 2006 on Infant Formulae and Amending Directive 1999/21/EC. Official Journal of the European Union. 30.12.2006:L401/1401/33 (accessed Apr 2, 2009). http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:401:0001:0033:EN:PDF.
16. DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease. National Institute on Aging, Martek Biosciences Corp (accessed Apr 2, 2009). http://clinicaltrials.gov/ct2/show/NCT00440050?term=dha+AND+alzheimers&rank=1.
17. Dickinson H.A., Mason J.M., Nicolson D.J., Campbell F., Beyer F., Cook J., Williams B., Ford G.A. Lifestyle Interventions to Reduce Raised Blood Pressure: A Systematic Review of Randomized Controlled Trials. J. Hypertens. 2006, 24:215-233.
18. Dobbing J., Sands J. Quantitative Growth and Development of Human Brain. Arch. Dis. Child. 1973, 48:757-767.
19. Dutta-Roy A.K. Transport Mechanisms for Long-Chain Polyunsaturated Fatty Acids in the Human Placenta. Am. J. Clin. Nutr. 2000, 71(1 Suppl):315S-322S.
20. Engler M.M., Engler M.B., Malloy M.J., Paul S.M., Kulkarni K.R., Mietus-Snyder M.L. Effect of Docosahexaenoic Acid on Lipoprotein Subclasses in Hyperlipidemic Children (The EARLY Study). Am. J. Cardiol. 2005, 95:869-871.
21. Food and Nutrition Board, Institute of Medicine of the National Academies Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids 2005, National Academies Press, Washington, DC.
22. Gibson R.A., Barclay D., Marshall H., Moulin J., Maire J.C., Makrides M. Safety of Supplementing Infant Formula with Long-Chain Polyunsaturated Fatty Acids and Bifidobacterium lactis in Term Infants: A Randomised Controlled Trial. Br. J. Nutr. 2009, Jan 12:1-8. [Epub ahead of print].
23. Griffin M.D., Sanders T.A., Davis I.G., Morgan L.M., Millward D.J., Lewis F., Slaughter S., Cooper J.A., Miller G.J., Griffin B.A. Effects of Altering the Ratio of Dietary n-6 to n-3 Fatty Acids on Insulin Sensitivity; Lipoprotein Size; and Postprandial Lipemia in Men and Postmenopausal Women Aged 45-70 y: The OPTILIP Study. Am. J. Clin. Nutr. 2006, 84:1290-1298.
24. Hartweg J., Farmer A.J., Perera R., Holman R.R., Neil H.A. Meta-analysis of the Effects on n-3 Polyunsaturated Fatty Acids on Lipoproteins and Other Emerging Lipid Cardiovascular Risk Markers in Patients with Type 2 Diabetes. Diabetologia. 2007, 50:1593-1602.
25. Henriksen C., Haugholt K., Lindgren M., Aurvag A.K., Ronnestad A., Gronn M., Solberg R., Moen A., Nakstad B., Berge R.K., et al. Improved Cognitive Development among Preterm Infants Attributable to Early Supplementation of Human Milk with Docosahexaenoic Acid and Arachidonic Acid. Pediatrics. 2008, 121:1137-1145.
26. Hoffman D., Ziegler E., Mitmesser S.H., Harris C.L., Diersen-Schade D.A. Soy-based Infant Formula Supplemented with DHA and ARA Supports Growth and Increases Circulating Levels of These Fatty Acids in Infants. Lipids. 2008, 43:29-35.
27. Innis S.M., Friesen R.W. Essential n-3 Fatty Acids in Pregnant Women and Early Visual Acuity Maturation in Term Infants. Am. J. Clin. Nutr. 2008, 87:548-557.
28. Iso H. Changes in Coronary Heart Disease Risk among Japanese. Circulation. 2008, 118:2725-2729.
29. Jacobson T.A. Role of n-3 Fatty Acids in the Treatment of Hypertriglyceridemia and Cardiovascular Disease. Am. J. Clin. Nutr. 2008, 87:1981S-1990S.
30. Jensen C.L., Voigt R.G., Prager T.C., Zou Y.L., Fraley J.K., Rozelle J.C., Turcich M.R., Llorente A.M., Anderson R.E., Heird W.C. Effects of Maternal Docosahexaenoic Acid Intake on Visual Function and Neurodevelopment in Breastfed Term Infants. Am. J. Clin. Nutr. 2005, 82:125-132.
31. Kannel W.B., Wolf P.A., Verter J., McNamara P.M. Framingham Study Insights on Hazards of Elevated Blood Pressure. JAMA 2008, 300:2545-2547.
32. Kelley D.S., Siegel D., Vemuri M., Mackey B.E. Docosahexaenoic Acid Supplementation Improves Fasting and Postprandial Lipid Profiles in Hypertriglyceridemic Men. Am. J. Clin. Nutr. 2007, 86:324-333.
33. Kelley D.S., Siegel D., Vemuri M., Chung G.H., Mackey B.E. Docosahexaenoic Acid Supplementation Decreases Remnant-like Particle-Cholesterol and Increases the (n-3) Index in Hypertriglyceridemic Men. J. Nutr. 2008, 138:30-35.
34. Kelley D.S., Siegel D., Fedor D.M., Adkins Y., Mackey B.E. DHA Supplementation Decreases Serum C-Reactive Protein and Other Markers of Inflammation in Hypertriglyceridemic Men. J. Nutr. 2009, [Epub ahead of print].
35. Koletzko B., Cetin I., Brenna J.T., Perinatal Lipid Intake Working Group, Child Health Foundation, Diabetic Pregnancy Study Group, European Association of Perinatal Medicine, European Association of Perinatal Medicine, European Society for Clinical Nutrition and Metabolism, European Society for Paediatric Gastroenterology, Hepatology and Nutrition, Committee on Nutrition, International Federation of Placenta Associations, International Society for the Study of Fatty Acids and Lipids Dietary Fat Intakes for Pregnant and Lactating Women. Br. J. Nutr. 2007, 98:873-877.
36. Koletzko B., Larqué E., Demmelmair H. Placental Transfer of Long-Chain Polyunsaturated Fatty Acids (LC-PUFA). J. Perinat. Med. 2007, 35:S5-S11.
37. Koletzko B., Lien E., Agostoni C., Böhles H., Campoy C., Cetin I., Decsi T., Dudenhausen J.W., Dupont C., Forsyth S., World Association of Perinatal Medicine Dietary Guidelines Working Group, et al. The Roles of Long-Chain Polyunsaturated Fatty Acids in Pregnancy; Lactation and Infancy: Review of Current Knowledge and Consensus Recommendations. J. Perinat. Med. 2008, 36:5-14.
38. Kris-Etherton P.M., Harris W.S., Appel L.J., American Heart Association, Nutrition Committee Fish Consumption; Fish Oil; Omega-3 Fatty Acids; and Cardiovascular Disease. Circulation 2002, 106:2747-2757.
39. Krotz F., Sohn H.Y., Klauss V. Antiplatelet Drugs in Cardiological Pactice: Established Strategies and New Developments. Vasc. Health Risk Manage. 2008, 4:637-645.
40. Kusumoto A., Ishikura Y., Kawashima H., Kiso Y., Takai S. Effects of Arachidonate-Enriched Triacylglycerol Supplementation on Serum Fatty Acids and Platelet Aggregation in Healthy Male Subjects with a Fish Diet. Br. J. Nutr. 2007, 98:626-635.
41. Lu G., Windsor S.L., Harris W.S. Omega-3 Fatty Acids Alter Lipoprotein Subfraction Distributions and the in vitro Conversion of Very Low Density Lipoproteins to Low Density Lipoproteins. J. Nutr. Biochem. 1999, 10:151-158.
42. Maclean C.H., Issa A.M., Newberry S.J., Mojica W.A., Morton S.C., Garland R.H., Hilton L.G., Traina S.B., Shekelle P.G. Effects of Omega-3 Fatty Acids on Cognitive Function with Aging; Dementia; and Neurological Diseases. Evid. Rep. Technol. Assess. (Summ.) 2005, 114:1-3.
43. Maki K.C., Van Elswyk M.E., McCarthy D., Hess S.P., Veith P.E., Bell M., Subbaiah P., Davidson M.H. Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women with Below Average Levels of High Density Lipoprotein Cholesterol. J. Am. Coll. Nutr. 2005, 24:189-199.
44. Makrides M., Gibson R.A., McPhee A.J., Collins C.T., Davis P.G., Doyle L.W., Simmer K., Colditz P.B., Morris S., Smithers L.G., et al. Neurodevelopmental Outcomes of Preterm Infants Fed High-Dose Docosahexaenoic Acid: A Randomized Controlled Trial. JAMA. 2009, 301:175-182.
45. Memory Improvement with Docosahexaenoic Acid Study (MIDAS) Martek Biosciences Corp (accessed Apr 2, 2009). http://clinicaltrials.gov/ct2/show/NCT00278135?term=midas&rank=2.
46. Minihane A.M., Kahn S., Leigh-Firbank E.C., Talmud P., Wright J.W., Murphy M.C., Griffin B.A., Williams C.M. ApoE Polymorphism and Fish Oil Supplementation in Subjects with an Atherogenic Lipoprotein Phenotype. Arterioscler. Thromb. Vasc. Biol. 2000, 20:1990-1997.
47. Oe H., Hozumi T., Murata E., Matsuura H., Negishi K., Matsumura Y., Iwata S., Ogawa K., Sugioka K., Takemoto Y., et al. Arachidonic Acid and Docosahexaenoic Acid Supplementation Increases Coronary Flow Velocity Reserve in Japanese Elderly Subjects. Heart. 2008, 94:316-321.
48. Putnam J., Carlson S., DeVoe P., Barness L. The Effect of Variations in Dietary Fatty Acids on the Fatty Acid Composition of Erythrocyte Phosphatidylcholine and Phosphatidylethanolamine in Human Infants. Am J Clin Nutr. 1982, 36:106-114.
49. Ryan A.S., Montalto M.B., Groh-Wargo S., Mimouni F., Sentipal-Walerius J., Doyle J., Siegman J.S., Thomas A.J. Effect of DHA-Containing Formula on Growth of Preterm Infants to 59 Weeks Postmenstrual Age. Am. J. Hum. Biol. 1999, 11:457-467.
50. Ryan A.S., Nelson E.B. Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study. Clin Pedi 2008, 47:355-362.
51. Ryan A.S., Keske M.A., Hoffman J.P., Nelson E.B. Clinical Overview of Algal-Docosahexaenoic Acid: Effects on Triglyceride Levels and Other Cardiovascular Risk Factors. Am. J. Ther. 2009, 16:183-192.
52. Sanders T.A., Gleason K., Griffin B., Miller G.J. Influence of an Algal Triacylglycerol Containing Docosahexaenoic acid (22: 6n-3) and Docosapentaenoic Acid (22: 5n-6) on Cardiovascular Risk Factors in Healthy Men and Women. Br. J. Nutr. 2006, 95:525-531.
53. Schaefer E.J., Bongard V., Beiser A.S., Lamon-Fava S., Robins S.J., Au R., Tucker K.L., Kyle D.J., Wilson P.W., Wolf P.A. Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer disease: The Framingham Heart Study. Arch. Neurol. 2006, 63:1545-1550.
54. Schwellenbach L.J., Olson K.L., McConnell K.J., Stolcpart R.S., Nash J.D., Merenich J.A. The Triglyceride-Lowering Effects of a Modest Dose of Docosahexaenoic Acid Alone versus in Combination with Low Dose Eicosapentaenoic Acid in Patients with Coronary Artery Disease and Elevated Triglycerides. J. Am. Coll. Nutr. 2006, 25:480-485.
55. Siahanidou T., Lazaropoulou C., Michalakakou K., Papassotiriou I., Bacoula C., Mandyla H. Oxidative Stress in Preterm Infants Fed a Formula Containing Long-Chain Polyunsaturated Fatty Acids (LCPUFA). Am. J. Perinatol. 2007, 24:475-479.
56. Siahanidou T., Margeli A., Lazaropoulou C., Karavitakis E., Papassotiriou I., Mandyla H. Circulating Adiponectin in Preterm Infants Fed Long-Chain Polyunsaturated Fatty Acids (LCPUFA)-Supplemented Formula-A Randomized Controlled Study. Pediatr. Res. 2008, 63:428-432.
57. Smithers L.G., Gibson R.A., McPhee A., Makrides M. Effect of Two Doses of Docosahexaenoic Acid (DHA) in the Diet of Preterm Infants on Infant Fatty Acid Status: Results from the DINO trial. Prostaglandins Leukot. Essent. Fatty Acids. 2008, 79:141-146.
58. Smithers L.G., Gibson R.A., McPhee A., Makrides M. Higher Dose of Docosahexaenoic Acid in the Neonatal Period Improves Visual Acuity of Preterm Infants: Results of a Randomized Controlled Trial. Am. J. Clin. Nutr. 2008, 88(4):1049-1056.
59. Theobald H.E., Goodall A.H., Sattar N., Talbot D.C., Chowienczyk P.J., Sanders T.A. Low-Dose Docosahexaenoic Acid Lowers Diastolic Blood Pressure in Middle-aged Men and Women. J. Nutr. 2007, 137:973-978.
60. Vanderhoof J.A. Hypoallergenicity and Effects on Growth and Tolerance of a New Amino Acid-based Formula with DHA and ARA. J. Pediatr. Gastroenterol. Nutr. 2008, 47:S60-S61.
61. Vasan R.S., Larson M.G., Leip E.P., Evans J.C., O'Donnell C.J., Kannel W.B., Levy D. Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease. N Engl J Med. 2001, 345:1291-1297.
62. Wang C., Harris W.S., Chung M., Lichtenstein A.H., Balk E.M., Kupelnick B., Jordan H.S., Lau J. N-3 Fatty Acids from Fish or Fish-Oil Supplements; But Not α -Linolenic Acid; Benefit Cardiovascular Disease Outcomes in Primary- and Secondary-Prevention Studies: A Systematic Review. Am. J. Clin. Nutr. 2006, 84:5-17.
63. Yuhas R., Pramuk K., Lien E.L. Human Milk Fatty Acid Composition from Nine Countries Varies Most in DHA. Lipids 2006, 41:851-858.
64. Yurko-Mauro K., et al. Results of the MIDAS Trial: Effects of Docosahexaenoic Acid on Physiological and Safety Parameters in Age-related Cognitive Decline. Abstract 09-A-2137-ALZ presented 7/12/09 at International Conference on Alzheimer's Disease (ICAD 2009) Vienna http://www.alz.org/icad/documents/abstracts/abstracts_dha_ICAD09.pdf.